306 related articles for article (PubMed ID: 32171757)
1. Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications.
Šimková A; Bušek P; Šedo A; Konvalinka J
Biochim Biophys Acta Proteins Proteom; 2020 Jul; 1868(7):140409. PubMed ID: 32171757
[TBL] [Abstract][Full Text] [Related]
2. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
[TBL] [Abstract][Full Text] [Related]
3. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.
Brennen WN; Rosen DM; Wang H; Isaacs JT; Denmeade SR
J Natl Cancer Inst; 2012 Sep; 104(17):1320-34. PubMed ID: 22911669
[TBL] [Abstract][Full Text] [Related]
4. Targeting fibroblast activation protein in cancer - Prospects and caveats.
Busek P; Mateu R; Zubal M; Kotackova L; Sedo A
Front Biosci (Landmark Ed); 2018 Jun; 23(10):1933-1968. PubMed ID: 29772538
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
Juillerat-Jeanneret L; Tafelmeyer P; Golshayan D
Expert Opin Ther Targets; 2017 Oct; 21(10):977-991. PubMed ID: 28829211
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast activation protein in remodeling tissues.
Jacob M; Chang L; Puré E
Curr Mol Med; 2012 Dec; 12(10):1220-43. PubMed ID: 22834826
[TBL] [Abstract][Full Text] [Related]
7. Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
Christiansen VJ; Jackson KW; Lee KN; Downs TD; McKee PA
Neoplasia; 2013 Apr; 15(4):348-58. PubMed ID: 23555181
[TBL] [Abstract][Full Text] [Related]
8. [FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.].
Pleshkan VV; Alekseenko IV; Tyulkina DV; Kyzmich AI; Zinovyeva MV; Sverdlov ED
Mol Gen Mikrobiol Virusol; 2016; 34(3):90-97. PubMed ID: 30383930
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α.
Keane FM; Nadvi NA; Yao TW; Gorrell MD
FEBS J; 2011 Apr; 278(8):1316-32. PubMed ID: 21314817
[TBL] [Abstract][Full Text] [Related]
10. From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment.
Zhang Z; Tao J; Qiu J; Cao Z; Huang H; Xiao J; Zhang T
Cell Oncol (Dordr); 2024 Apr; 47(2):361-381. PubMed ID: 37726505
[TBL] [Abstract][Full Text] [Related]
11. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy.
Hamson EJ; Keane FM; Tholen S; Schilling O; Gorrell MD
Proteomics Clin Appl; 2014 Jun; 8(5-6):454-63. PubMed ID: 24470260
[TBL] [Abstract][Full Text] [Related]
12. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy.
Brennen WN; Isaacs JT; Denmeade SR
Mol Cancer Ther; 2012 Feb; 11(2):257-66. PubMed ID: 22323494
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma.
Wong PF; Gall MG; Bachovchin WW; McCaughan GW; Keane FM; Gorrell MD
Peptides; 2016 Jan; 75():80-95. PubMed ID: 26621486
[TBL] [Abstract][Full Text] [Related]
14. The role of fibroblast activation protein in health and malignancy.
Fitzgerald AA; Weiner LM
Cancer Metastasis Rev; 2020 Sep; 39(3):783-803. PubMed ID: 32601975
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity.
Edosada CY; Quan C; Wiesmann C; Tran T; Sutherlin D; Reynolds M; Elliott JM; Raab H; Fairbrother W; Wolf BB
J Biol Chem; 2006 Mar; 281(11):7437-44. PubMed ID: 16410248
[TBL] [Abstract][Full Text] [Related]
16. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR
Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147
[TBL] [Abstract][Full Text] [Related]
17. A specific, transmembrane interface regulates fibroblast activation protein (FAP) homodimerization, trafficking and exopeptidase activity.
Wonganu B; Berger BW
Biochim Biophys Acta; 2016 Aug; 1858(8):1876-82. PubMed ID: 27155568
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.
Lai D; Ma L; Wang F
Int J Oncol; 2012 Aug; 41(2):541-50. PubMed ID: 22614695
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies.
Kelly T; Huang Y; Simms AE; Mazur A
Int Rev Cell Mol Biol; 2012; 297():83-116. PubMed ID: 22608558
[TBL] [Abstract][Full Text] [Related]
20. Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics.
Zhang HE; Hamson EJ; Koczorowska MM; Tholen S; Chowdhury S; Bailey CG; Lay AJ; Twigg SM; Lee Q; Roediger B; Biniossek ML; O'Rourke MB; McCaughan GW; Keane FM; Schilling O; Gorrell MD
Mol Cell Proteomics; 2019 Jan; 18(1):65-85. PubMed ID: 30257879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
